VF
ATRA icon

Virtu Financial’s Atara Biotherapeutics ATRA Stock Holding History

Virtu Financial’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-739
Closed -$9K – 1401
2023
Q4 		$9K Buy
739
+326
+79% +$7.6K ﹤0.01% 1415
2023
Q3 		$15K Sell
413
-77
-16% -$3.43K ﹤0.01% 1050
2023
Q2 		$20K Buy
+490
New +$27.7K ﹤0.01% 1259
2021
Q3 		– Sell
-507
Closed -$197K – 1491
2021
Q2 		$197K Buy
+507
New +$181K 0.02% 1002
2018
Q3 		– Sell
-299
Closed -$274K – 1527
2018
Q2 		$274K Buy
+299
New +$321K 0.02% 1228

Other funds holding ATRA

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Virtu Financial's ATRA Position: Q1 2024 in Review

Virtu Financial sold out of Atara Biotherapeutics (ATRA) in Q1 2024, closing a stake of 739 shares — an estimated $9K sold.

Virtu Financial first reported a position in ATRA in Q2 2018 and held it in 5 quarters. The position peaked at $274K in Q2 2018. 82 funds tracked by Wall St. Rank hold ATRA as of Q1 2024.

  • Virtu Financial reported no remaining Atara Biotherapeutics position as of Q1 2024 after selling out during the quarter.
  • Virtu Financial sold 739 Atara Biotherapeutics shares in Q1 2024, an estimated $9K.
  • Virtu Financial first reported a position in Atara Biotherapeutics in Q2 2018 and held it in 5 quarters.
  • Virtu Financial's Atara Biotherapeutics position peaked at $274K in Q2 2018.
  • 82 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q1 2024.

Based on Virtu Financial's 13F filing for Q1 2024, filed 20 May 2024.